Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

NCT01688713 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases
Non-small Cell Lung Cancer

Interventions

DRUG: Icotinib

Sponsor

Zhejiang Cancer Hospital